# Examination of the Lipid Metabolism of the Liver After Choline Substitution in Cystic Fibrosis

> **NCT03312140** · NA · COMPLETED · sponsor: **University Hospital Tuebingen** · enrollment: 10 (actual)

## Conditions studied

- Cystic Fibrosis Liver Disease

## Interventions

- **DRUG:** Choline Chloride

## Key facts

- **NCT ID:** NCT03312140
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11-06
- **Primary completion:** 2016-04-24
- **Final completion:** 2017-02-08
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2017-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03312140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03312140, "Examination of the Lipid Metabolism of the Liver After Choline Substitution in Cystic Fibrosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03312140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*